KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 1

Cloning and molecular characterization of thiol-specific antioxidant gene of Leishmania tropica Turkey isolate

Hamza ÖZAVCI
Mustafa KAPLAN
Sayfa
392–402
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

LtTSA protein consisting of 199 amino acids was found to have 7 differentantigenic regions.Conclusion: LtTSA and its encoded TSA protein were found to be highly immunogenic and similar to TSA proteins previously testedas a vaccine candidate.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Thiol-specific antioxidant (TSA) protein is one of the most promising molecules among candidates for vaccineagainst cutaneous leishmaniasis.
📊
Temel Bulgular & Veri:It was found to be significantly protective against different Leishmania species.
💡
Sonuç & Katkı:LtTSA protein consisting of 199 amino acids was found to have 7 differentantigenic regions.Conclusion: LtTSA and its encoded TSA protein were found to be highly immunogenic and similar to TSA proteins previously testedas a vaccine candidate.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Thiol-specific antioxidant (TSA) protein is one of the most promising molecules among candidates for vaccineagainst cutaneous leishmaniasis. It was found to be significantly protective against different Leishmania species. In this study, cloningand molecular characterization of thiol-specific antioxidant gene of L. tropica Turkey isolate (LtTSA) were aimed.Materials and methods: LtTSA was amplified by PCR using the specific primers of TSA gene and cloned into the pcDNA3.1 vector.The cloning was confirmed by PCR screening, restriction enzyme reactions, and DNA sequence analysis. Finally, three-dimensionalstructure and antigenic properties of the protein encoded by the LtTSA were determined.Results: Six hundred base pair bands belonging to LtTSA were shown with electrophoresis. It was found that LtTSA and its encodedprotein have high similarity with different Leishmania species. LtTSA protein consisting of 199 amino acids was found to have 7 differentantigenic regions.Conclusion: LtTSA and its encoded TSA protein were found to be highly immunogenic and similar to TSA proteins previously testedas a vaccine candidate.

🔖

Bu Makaleye Atıf Yap

ÖZAVCI, H., KAPLAN, M. (2022). Cloning and molecular characterization of thiol-specific antioxidant gene of Leishmania tropica Turkey isolate. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 1, 392–402. https://ajindex.com/articles/610094

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199
  2. Yazar S, Kuk S, Miman Ö, Saygı G. Saygı’nın Temel Tıbbi Parazitolojisi. Kayseri, Turkey: Erciyes Üniversitesi Yayınları; 2016 (in Turkish)
  3. World Health Organisation. Investing to overcome the global impact of neglected tropical diseases: third world health organisation report on neglected diseases. 2015
  4. Harris M, Reza J. Global report for research on infectious disease of poverty. World Health Organization. 2012
  5. Choi CM, Lerner EA. Leishmaniasis as an emerging infection. J Investig Dermatol Symp Proc 2001; 6: 175-182
  6. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol and Infect Dis 2004; 27: 305-318
  7. Showler AJ, Boggild AK. Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015. Curr Infect Dis Rep 2015; 17: 489
  8. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M. Leishmaniasis worldwide and global estimates of its insidance. PloS One 2012; 7: e35671
  9. World Health Organisation. Control of the Leishmaniases. Geneva, Switzerland: WHO Technical Report Series; 2010
  10. Ghosh M, Bandyopadhyay S. Present status of antileishmanial vaccines. Mol Cell Biochem 2003; 253: 199-205
  11. Nagill R, Kaur S. Vaccine candidates for leishmaniasis: a review. Int Immunopharmacol 2011; 11: 1464-1488
  12. Coler RN, Skeiky YA, Bernards K, Greeson K, Carter D, Cornellison CD, Modabber F, Campos-Neto A, Reed SG. Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis. Infect Immun 2002; 70: 4215-4225
  13. Fatemeh G, Fatemeh T, Zohreh S, Abdolhosein D, Mohammad Zahir H, Mehdi M. Cloning of a recombinant plasmid encoding thiol-specific antioxidant antigen (TSA) gene of Leishmania major and expression in the Chinese hamster ovary cell line. Malays J Med Sci 2012; 19: 15-19
  14. Ghaffarifar F, Jorjani O, Sharifi Z, Dalimi A, Hassan ZM, Tabatabaie F, Khoshzaban F, Hezarjaribet HZ. Enhancement of immune response induced by DNA vaccine cocktail expressing complete LACK and TSA genes against Leishmania major. APMIS 2013; 121: 290-298
  15. Gillespie PM, Beaumier CM, Strych U, Hayward T, Hotez PJ, Bottazzi ME. Status of vaccine research and development of vaccines for leishmaniasis. Vaccine 2016; 34: 2992-2995
  16. Jirata D, Kuru T, Genetu A, Barr